Edgewise Therapeutics, Inc. (EWTX)
39.57
-0.45
(-1.12%)
USD |
NASDAQ |
Oct 07, 16:00
39.59
+0.02
(+0.05%)
After-Hours: 20:00
Edgewise Therapeutics EPS Diluted (Quarterly) : -0.5324 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5324 |
| March 31, 2026 | -0.4576 |
| December 31, 2025 | -0.4737 |
| September 30, 2025 | -0.3855 |
| June 30, 2025 | -0.3442 |
| March 31, 2025 | -0.4289 |
| December 31, 2024 | -0.4187 |
| September 30, 2024 | -0.3638 |
| June 30, 2024 | -0.3368 |
| March 31, 2024 | -0.3258 |
| December 31, 2023 | -0.4654 |
| September 30, 2023 | -0.4052 |
| June 30, 2023 | -0.3387 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.361 |
| December 31, 2022 | -0.307 |
| September 30, 2022 | -0.3375 |
| June 30, 2022 | -0.3238 |
| March 31, 2022 | -0.2959 |
| December 31, 2021 | -0.2565 |
| September 30, 2021 | -0.2627 |
| June 30, 2021 | -0.2102 |
| March 31, 2021 | -0.1383 |
| December 31, 2020 | -0.1289 |
| September 30, 2020 | -0.074 |
| June 30, 2020 | -0.0803 |
| March 31, 2020 | -0.0647 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | 2.578 |
| Fulcrum Therapeutics, Inc. | -0.3433 |
| Definium Therapeutics, Inc. | -1.436 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.33M |
| Total Expenses (Quarterly) | 57.33M |
| Enterprise Value | 3.808B |
| Earnings Yield | -4.67% |
| Normalized Earnings Yield | -4.673 |